Bensen Daniel 4
4 · Tyra Biosciences, Inc. · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Tyra Biosciences (TYRA) Chief Discovery Officer Daniel Bensen Sells Shares
What Happened
Daniel Bensen, Chief Discovery Officer of Tyra Biosciences (TYRA), sold a total of 8,000 shares in two open‑market transactions on February 12, 2026, generating combined proceeds of approximately $262,965. The sales broke down as 2,128 shares at a weighted average price of $31.50 (≈ $67,036) and 5,872 shares at a weighted average price of $33.37 (≈ $195,929). These were sales (not purchases), which are commonly routine disposals rather than a direct bullish signal.
Key Details
- Transaction date: February 12, 2026; Form 4 filed February 13, 2026 (appears timely).
- Shares sold: 2,128 @ $31.50 (weighted avg; actual prices $31.02–$31.75) and 5,872 @ $33.37 (weighted avg; actual prices $32.98–$33.85).
- Total shares sold: 8,000; total proceeds: ~$262,965.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted November 5, 2024. Exact per‑trade price breakdowns are available from the issuer on request.
- Transaction code: S = Sale.
Context
Sales executed under a pre‑arranged 10b5‑1 plan are scheduled trades intended to avoid timing based on inside information; they are common among executives and often indicate routine portfolio management rather than a view on the company’s prospects. For retail investors, purchases typically carry more direct informational value than routine insider sales.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-02-12$31.50/sh−2,128$67,036→ 152,853 total - Sale
Common Stock
[F1][F3]2026-02-12$33.37/sh−5,872$195,929→ 146,981 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $31.02 to $31.75. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $32.98 to $33.85. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.